<i>APOBEC3B</i> Gene Expression in Ductal Carcinoma In Situ and Synchronous Invasive Breast Cancer
The underlying mechanism of the progression of ductal carcinoma in situ (DCIS), a non-obligate precursor of invasive breast cancer (IBC), has yet to be elucidated. In IBC, Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3B (APOBEC3B) is upregulated in a substantial proportion of cas...
Main Authors: | Anieta M. Sieuwerts, Shusma C. Doebar, Vanja de Weerd, Esther I. Verhoef, Corine M. Beauford, Marie C. Agahozo, John W.M. Martens, Carolien H.M. van Deurzen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/8/1062 |
Similar Items
-
APOBEC3B, a molecular driver of mutagenesis in human cancers
by: Jun Zou, et al.
Published: (2017-05-01) -
Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types
by: Zhishan Chen, et al.
Published: (2019-09-01) -
APOBEC3B Activity Is Prevalent in Urothelial Carcinoma Cells and Only Slightly Affected by LINE-1 Expression
by: Ananda Ayyappan Jaguva Vasudevan, et al.
Published: (2018-09-01) -
Perturbation of base excision repair sensitizes breast cancer cells to APOBEC3 deaminase-mediated mutations
by: Birong Shen, et al.
Published: (2020-01-01) -
Small-Angle X-ray Scattering Models of APOBEC3B Catalytic Domain in a Complex with a Single-Stranded DNA Inhibitor
by: Fareeda M. Barzak, et al.
Published: (2021-02-01)